We can accelerate drug discovery on demand
Using a differentiated approach to solve for the unsolvable — targeting shape shifting intrinsically disordered proteins — we quickly and accurately identify novel and optimal binding mechanisms of action to drive drug discovery.
Our proprietary platform is centered on identifying chemical matter through molecular screening followed by optimizing chemical matter using machine learning and artificial intelligence.
The science we’ve built produces disease-modifying assets rapidly and reliably.
Our novel molecular insights are limitless.
Screening Technology
We employ a multidimensional, microfluidics-based high throughput molecular screen to identify hits, determine their binding mechanisms of action, and drive drug discovery.
Machine Learning/AI
Our ML/AI engine is foundational to everything we do. We use proprietary datasets frombiochemical/biophysical assays and genomics to build our models. We then apply these models acrossour drug discovery activities–including in target discovery, hit identification, indication selection, anddrug optimization.
